Stockreport

Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results

Generation Bio Co. - Common stock  (GBIO) 
PDF -  Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP [Read more]